Bruno Giros

Bruno Giros

Room E-3207, Perry Pavillion

6875 Boulevard Lasalle
Montréal, QC
H4H 1R3

(514) 761-6131 x3142

(514) 762-3034

Research area: 
Basic Neuroscience / Animal Research

Research Theme: 
Psychosis and Neurodevelopmental Disorders

Professor of Psychiatry, Department of Medicine, McGill University
Canada Research Chair for the Neurobiology of Mental Disorders
Graham Boeckh Chair for Schizophrenia Research
Research Director at CNRS

Pathophysiology of Psychiatric Disorders

Our research group is genuinely interested in the Pathophysiology of Psychiatric Disorders, investigating the molecular and cellular processes that are involved in the appearance of the main symptoms of these disorders. We are more precisely focusing on two devastating disorders, Schizophrenia and Major Depression, which respectively account worldwide for 1.5% and 20% of the people in the general population. To reach our objectives, we combined molecular, biochemical, electrophysiological and behavioral approaches. For these studies, we are generating original animal models with genetic engineering, and we used “state of the art” techniques, as optogenetic stimulations in the awake animal or miRNA transcriptomic analysis for example.

• For schizophrenia, we are presently unraveling unsuspected effects of dopamine in the frontal cortex and the hippocampus, and starting to understand precisely, at the cellular and network levels, how they are put into play.

• For depression, our fundamental and preclinical projects are investigating mechanisms contributing to individual vulnerability or resistance (resiliency) to stress and the etiology of depression.

The combination of our approaches will not only enriches our hypotheses, but will also offers a strong potential to recognize common mechanisms occurring in these two major psychiatric disorders. All our studies aim, at the mid-term, to be translated into experimental medicine protocols in collaboration with psychiatrists.

Rocchetti et al., Presynaptic D2 Dopamine Receptors Control Long-Term Depression Expression and Memory Processes in the Temporal Hippocampus. 2015, Biol. Psychiatry, 77, 513-525.
Couroussé et al., Brain Organic Cation Transporter-2 controls response and vulnerability to stress and GSK3ß signaling.. 2014, Mol Psychiatry, in press.
DeGois S. et al., Ctr9, a protein of the transcription complex Paf1, regulates the Dopamine Transporter activity at the plasma membrane. J. Biol. Chem., in press.

Giros B., C. Gros, B. Solhonne & J.C. Schwartz. Characterization of aminopeptidases responsible for inactivating endogenous enkephalin in brain slices using peptidase inhibitors and antiaminopeptidase M antibodies. Molec. Pharmacol., 1986, 29, 281-287.

Giros B., P. Sokoloff, M.P. Martres, J.F. Riou, J.L. Emorine & J.-C. Schwartz. Alternative splicing directs the expression of two D-2 dopamine receptor isoforms. Nature, 1989, 342, 923-926.

Sokoloff P., B. Giros, M.P. Martres, M.L.Bouthenet & J.C. Schwartz. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature, 1990, 347,146-151.

Bouthenet M.L., E. Souil, M.P. Martres, P. Sokoloff, B. Giros & J.C. Schwartz. Localization of dopamine D3 receptor RNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res., 1991, 564, 203-219.

Piomelli, D., C. Pilon, B. Giros, P. Sokoloff, M.P. Martres & J.C. Schwartz. Dopamine activation of the arachidonic acid cascade via a modulatory mechanism as a basis for D1/D2 receptor synergism. Nature, 1991, 353, 164-167.

Giros B., S. El Mestikawy, L. Bertrand & M. G. Caron. Cloning and functionnal characterization of a cocaine sensitive dopamine transporter. 1991, FEBS Letters, 295, 149-154.

Giros B. , S. El Mestikawy, N. Godinot, K. Zheng, H. Han, T. Yang-Feng & M.G. Caron. Cloning, pharmacological characterization and chromosome assignment of the human dopamine transporter. Mol. Pharmacol., 1992, 42, 383-390.

Giros B. & M.G. Caron. Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci., 1993, 14, 43-49.

Kim K.-M, S.F. Kingsmore, H. Han, T. L. Yang.Feng, N. Godinot, M.F. Seldin, M.G. Caron & B. Giros. Cloning of the human glycine transporter Type1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genome. Mol. Pharmacol., 1994, 45, 608-617.

Giros B., M. Jaber, S.R. Jones, R.M. Wightman & M.G. Caron. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. 1996, Nature, 379, 606-612.

Jaber M., W.J. Koch, H. Rockman, B. Smith, R.A. Bond, K.K. Sulik, J. Ross Jr., R.J. Lefkowitz, M.G. Caron & B. Giros. Essential role of ?-Adrenergic Receptor Kinase-1 in cardiac development and function. 1996, Proc. Natl. Acad. Sci. USA, 93, 12974-12979.

Spielewoy, C., F. Gonon, C. Roubert, V. Fauchey, M. Jaber, M. Caron, B. Roques, M. Hamon, C. Betancur, R. Maldonado & B. Giros. Increased rewarding properties of morphine in dopamine-transporter knockout mice. 2000, Eur. J. Neurosci., 12, 1827-1837.

Roubert, C., Cox, P.J., Bruss, M., Hamon, M., Bonisch, H. & Giros, B. Determination of Residues in the Norepinephrine Transporter that are Critical for Tricyclic Antidepressant Affinity. 2001, J Biol Chem., 276: 8254-8260.

Sagné C., Agulhon C., Ravassard P., Darmon M., Hamon M., El Mestikawy S., Gasnier B. & Giros B. Identification and characterisation of a lysosomal transporter for small neutral amino acids. 2001, Proc. Natl. Acad. Sci. USA, 98 :7206-7211.

Gras C., Herzog E., Bellenchi G.C., Bernard V., Ravassard P., Pohl M., Gasnier B., Giros B. & S. El Mestikawy. A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. 2002, J. Neurosci., 22, 5442-5451.

Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg Ic, Soderstrom H, Giros B, Leboyer M, Gillberg C, & Bourgeron T; Paris Autism Research International Sibpair Study.. Mutations of the X-linked neuroligins HNL3 and HNL4X are associated with autism. 2003, Nature genetics, 34, 27-29.

Agulhon C, Rostaing P, Ravassard P, Sagne C, Triller A & Giros B. The lysosomal amino acid transporter LYAAT-1 in the rat central nervous system: an in situ hybridization and immunohistochemical study. 2003 J. Comp. Neurol. 462, 71-89.

Vialou V, Amphoux A, Zwart R, Giros B, & Gautron S Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation. J Neurosci. 2004 24, 2846-2851.

Tzavara ET, Li DL, Moutsimilli L, Bisogno T, Marzo VD, Phebus LA, Nomikos GG, Giros B. Endocannabinoids Activate Transient Receptor Potential Vanilloid 1 Receptors to Reduce Hyperdopaminergia-Related Hyperactivity: Therapeutic Implications. Biological Psychiatry, 2006, 59, 508-515.

Vinatier J., Herzog E., Plamont M.A., Wojcik S., Schmidt A., Brose N., Daviet L., El Mestikawy S., Giros B. Interaction between the vesicular glutamate transporter type 1 and endophilin A1, a protein essential for endocytosis. 2006, J. Neurochem 97, 1111-1125.

Bacq A, Balasse L, Biala G, Guiard B, Gardier A, Schinkel A, Louis F, Vialou V, Martres MP, Hamon M, Giros B, Gautron S. Organic cation transporter 2 controls norepinephrine and serotonin clearance in the brain and can modulate the neurochemical and behavioral responses to antidepressants. Molecular Psychiatry, 2012, 17, 926-939.

Farley S, Dumas S, El Mestikawy S, Giros B. Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: Effects of fluoxetine and MK-801. Neuropharmacology, 2012, 62, 503-517.

Manitt C, Eng C, Pokinko M, Ryan RT, Torres Berrío A, Grant A, Yogendran SV, Daubaras MJJ, Schmidt ERE, Krimpenfort P, Cooper HM, Pasterkamp RJ, Kolb B, Wong TP, Nestler EJ, Giros B, Flores C. The netrin receptor DCC (Deleted in Colorectal Cancer) is an adolescence-specific guide for the maturation of mesocortical dopamine functions. 2013 Tranlational Psychiatry, 17, e338

Blum ID, Zhu L, Moquin L, Kokoeva M, Gratton A, Giros B, Storch KF. A highly-tunable dopaminergic oscillator generates ultradian rhythms of behavioral arousal. Elife. 2014 Dec 29;3. doi: 10.7554/eLife.05105.

Rocchetti J, Isingrini E, Dal Bo G, Sagheby S, Tronche F, Moquin L, Gratton A, Levesque D, Wong TP, Rubinstein M, Giros B. Presynaptic D2 Dopamine Receptors Control Long-Term Depression Expression and Memory Processes in the Temporal Hippocampus. Biological Psychiatry, 2015, 77, 513-525.

Couroussé T, Bacq A, Belzung C, Guiard B, Balasse L, Louis F, Le Guisquet A-M, Gardier AM, Schinkel AH, Giros B, Gautron S. Brain Organic Cation Transporter-2 controls response and vulnerability to stress and GSK3ß signaling. Molecular Psychiatry, 2015, in press.

DeGois S, Slama P, Pietrancosta N, Bouvrais-Veret C, Louis F, Daviet L, Giros B. Ctr9, a protein of the transcription complex Paf1, regulates the Dopamine Transporter activity at the plasma membrane. J. Biol. Chem., 2015, in press.

Years                     Laboratory                                                  Director
1983-1984 U-109 INSERM, Paris, France Jean-Charles Schwartz
1984 Lab. Neuro. Exp., Rouen, France Jean Costentin
1984-1987 U-109 INSERM, Paris, France Jean-Charles Schwartz
1987 Genentech, San Francisco, USA Bernard Malfroy
1988-1991 U-109 INSERM, Paris, France Jean-Charles Schwartz
1991-1994 HHMI, Duke Univ., Durham, USA Marc G. Caron
1994-1998 U-288 INSERM, Paris, France Michel Hamon
1999-2008 U-513 INSERM, Créteil, France Bruno Giros
2009-2013 CNRS UMR7224 INSERM 952 Bruno Giros
2008- Douglas Hospital Research Center Bruno Giros



Bruno Giros authored over 170 publications (Hf=52), has been recognized by the Institute for Scientific Information as a “Most Highly Cited Scientist” in the area of pharmacology, and has received numerous awards, including the very prestigious “Médaille d’Argent” from the CNRS.

Postdoctoral fellows:
Quentin RAINER

PhD students:

MS students:
Elisa GUMA
Kathleen XU

Lab Manager:

Animal technician:

Recent Publications

McGill Logo

CIUSSS ouest montreal logo


  • Douglas Hospital
  • Dobell Pavillion
  • Brain imaging centre